# Lila Sciences

> Lila Sciences is an AI company founded in 2023 building "Scientific Superintelligence" — a scientific reasoning model trained on experimental rather than internet data, coupled to autonomous robotic laboratory networks it calls AI Science Factories, that generates hypotheses, designs and runs experiments, and learns from the results. It sells two offerings: Catalyst (an operating system for science that accelerates an organization's existing research) and Creation (a partnership model for generating discoveries, launching products, and founding companies).

Generated by the API Evangelist enrichment pipeline on 2026-07-19 from the Lila Sciences public website. Lila Sciences does not publish an llms.txt of its own, nor a public developer API, developer portal, SDKs, or machine-readable API artifacts. This file is a generated company profile, not a provider-published document.

## Company

- [Lila Sciences](https://www.lila.ai/): Company homepage.
- [About](https://www.lila.ai/about): Mission — "Building Scientific Superintelligence to solve humankind's greatest challenges."
- [Technology](https://www.lila.ai/tech): The scientific reasoning model, verifiers and instruments, AI Science Factories, and continuous policy optimization.
- [Solutions](https://www.lila.ai/solutions): How Lila engages with partners.
- [Team](https://www.lila.ai/team): Leadership and scientific staff. Geoffrey von Maltzhan is CEO and co-founder.
- [Open Roles](https://www.lila.ai/open-roles): Careers.
- [Contact](https://www.lila.ai/contact): press@lila.ai for media, partnerships@lila.ai for partnerships. Locations: Cambridge MA, San Francisco CA, London UK.

## Products

- [Catalyst](https://www.lila.ai/lila-catalyst): An operating system for science, applied to an organization's existing research programs.
- [Creation](https://www.lila.ai/lila-creation): Partnership model for generating new discoveries, launching products, and creating new companies.

## Industries

- [Therapeutics](https://www.lila.ai/industries/therapeutics): mRNA, proteins, antibodies, cell therapies, small molecules.
- [Advanced Materials](https://www.lila.ai/industries/advanced-materials)
- [Chemicals](https://www.lila.ai/industries/chemicals)
- [Energy & Environment](https://www.lila.ai/industries/energy-and-environment)
- [Oil & Gas](https://www.lila.ai/industries/oil-and-gas)
- [Aerospace & Defense](https://www.lila.ai/industries/aerospace-and-defense)
- [Biotech](https://www.lila.ai/industries/biotech)

## News

- [News and Blog](https://www.lila.ai/news): Company announcements and technical posts.
- Announced a $200M seed round in March 2025 and closed a $350M Series A in October 2025 (~$550M total), with investors including General Catalyst and NVIDIA, at a reported valuation above $1.3B.
- Collaborates with NVIDIA on the BioNeMo Agent Toolkit.
- Named #25 on the 2026 CNBC Disruptor 50 list and to Fast Company's Top 10 Most Innovative AI Companies of 2026.

## Legal

- [Terms of Use](https://www.lila.ai/terms-of-use)
- [Privacy Policy](https://www.lila.ai/privacy-policy)

## API surface

Lila Sciences publishes no public API as of 2026-07-19. Probes of api.lila.ai, docs.lila.ai, developer.lila.ai, platform.lila.ai, app.lila.ai, and catalyst.lila.ai returned no DNS or no response; /openapi.json, /docs, /developers, and the /.well-known/ discovery surface all returned 404. There is no public GitHub organization at github.com/lila-sciences or github.com/lilasciences. Access to Catalyst appears to be sold through direct partnership rather than self-serve developer signup.